Amrutanjan Health Care Limited · NSE:AMRUTANJAN
Amrutanjan Health Care — H1 FY22 Earnings Presentation
18 slides from Amrutanjan Health Care's earnings presentation, Nov 9, 2021
Slide 1: Exchange filing cover letter
November 09 2021 AHCL/ SE/ 43/2021-22 The National Stock Exchange of India Limited BSE Limited “Exchange Plaza”, C-1, Block G Department of Corporate Services Bandra-Kurla Complex, Bandra (E) 1st Floor, Mumbai 400 051 PJ. Towers, Dalal Street, ISIN: INEO98F01031 Mumbai 400 001 Scrip Code: 590006 be
Slide 2: Amrutanjan Health Care Limited Investor Presentation
Amrutanjan Health Care Limited Investor Presentation Quarter & Half Year Ended 30th September 2021 Date: 9th November 2021
Slide 3: Contents
Contents a. Business Update b. H1 FY22 Performance c. Q2 FY22 Performance d. Way Forward Investor Presentation | Quarter and Half Year Ended 30th September 2021 2
Slide 4: Business Update
Business Update Investor Presentation | Quarter and Half Year Ended 30th September 2021 3
Slide 5: Business Update
Business Update • Certain secular consumer trends are continuing from last year - for instance purchase of health care products. • ORS category is at early stages of growth, like we saw with Sanitary napkins. • We are scaling Comfy steadily and this year saw new secondary sales at all-time high set
Slide 6: Business Update
Business Update Investor Presentation | Quarter and Half Year Ended 30th September 2021 5
Slide 7: New Amrutanjan Stop Pain Dental Gel
Business Update AMRUTANJAN STOP PAIN DENTAL GEL NEWUCT O D P R Investor Presentation | Quarter and Half Year Ended 30th September 2021 6
Slide 8: H1 FY22 Performance
H1 FY22 Performance Investor Presentation | Quarter and Half Year Ended 30th September 2021 7
Slide 9: Financials – H1 FY22
Financials – H1 FY22 (Rs. in Crores) Gross Sales Profit Before Tax Profit After Tax 208.50 42.64 31.91 152.26 40.05 29.98 H1 FY22 H1 FY21 H1 FY22 H1 FY21 H1 FY22 H1 FY21 Growth: 36.94% Growth: 6.47% Growth: 6.44% Investor Presentation | Quarter and Half Year Ended 30th September 2021 8
Slide 10: Expenses – H1 FY22
Expenses – H1 FY22 (Rs. in Crores) Employee benefits expense 24.33 18.96 H1 FY22 H1 FY21 Increase: 28.32% Advt and Selling Exp Other Expenses 26.75 16.41 12.47 11.85 H1 FY22 H1 FY21 H1 FY22 H1 FY21 Increase: 125.74% Increase: 31.60% Investor Presentation | Quarter and Half Year Ended 30th September
Slide 11: Financials – H1 FY22 – OTC Division
Financials – H1 FY22 – OTC Division (Rs. in Crores) Gross Sales - OTC 189.61 144.82 Notes: • Key raw material - Menthol Crystal price is lower when compared to H1 FY21. H1 FY22 H1 FY21 Growth: 30.93% • The prices of packing materials are higher when compared to H1 FY21. Gross Sales - Comfy • Adverti
Slide 12: Financials – H1 FY22 – Beverage Division
Financials – H1 FY22 – Beverage Division (Rs. in Crores) Gross Sales - Beverages 18.16 Notes: 7.05 • Gross Margin has improved by 2,199 basis points when compared to H1 H1 FY22 H1 FY21 FY21 mainly due to product mix. Growth: 157.59% • Advertisement spend is at 2.48 cr Gross Sales - Electro Plus for
Slide 13: Q2 FY22 Performance
Q2 FY22 Performance Investor Presentation | Quarter and Half Year Ended 30th September 2021 12
Slide 14: Financials – Q2 FY22
Financials – Q2 FY22 (Rs. in Crores) Profit Before Tax Profit After Tax 23.55 31.39 26.36 19.85 Q2 FY22 Q2 FY21 Q2 FY22 Q2 FY21 Growth: 20.29% Note: The reduction in PBT from Rs. 31.39 crores (Q2 FY21) to Rs. 26.36 crores (Q2 FY22) was predominantly due to the additional investment made in growing b
Slide 15: Financials – Q2 FY22
Financials – Q2 FY22 (Rs. in Crores) Growth: 17.70% Growth: 100% Gross Sales - Comfy Gross Sales - Electro Plus 21.51 4.65 14.67 1.88 Q2 FY22 Q2 FY21 Q2 FY22 Q2 FY21 Growth: 46.63% Growth: 147.34% Investor Presentation | Quarter and Half Year Ended 30th September 2021 14
Slide 16: Way Forward
Way Forward Investor Presentation | Quarter and Half Year Ended 30th September 2021 15
Slide 17: Way Forward
Way Forward We remain focused on executing our key priorities: • Continue the growth rhythm • Expand distribution • Go digital • Grow E-Commerce vertical • Costs control Investor Presentation | Quarter and Half Year Ended 30th September 2021 16
Slide 18: Investor Presentation | Quarter and Half Year Ended 30th September 2021
Investor Presentation | Quarter and Half Year Ended 30th September 2021 17
Amrutanjan Health Care — H1 FY22 Earnings Presentation on 6ix